Cowen AND Company LLC Trims Position in scPharmaceuticals Inc. (NASDAQ:SCPH)

Cowen AND Company LLC lessened its holdings in scPharmaceuticals Inc. (NASDAQ:SCPHFree Report) by 2.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,795,647 shares of the company’s stock after selling 42,271 shares during the period. scPharmaceuticals makes up about 0.9% of Cowen AND Company LLC’s investment portfolio, making the stock its 27th largest position. Cowen AND Company LLC owned about 5.01% of scPharmaceuticals worth $12,785,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. BlackRock Inc. increased its position in scPharmaceuticals by 1,445.7% in the second quarter. BlackRock Inc. now owns 1,729,428 shares of the company’s stock worth $17,623,000 after purchasing an additional 1,617,539 shares during the last quarter. State Street Corp increased its position in scPharmaceuticals by 1,869.8% during the second quarter. State Street Corp now owns 1,015,638 shares of the company’s stock valued at $10,349,000 after acquiring an additional 964,078 shares during the last quarter. Millennium Management LLC increased its position in scPharmaceuticals by 3,161.5% during the fourth quarter. Millennium Management LLC now owns 825,725 shares of the company’s stock valued at $5,920,000 after acquiring an additional 800,408 shares during the last quarter. Rubric Capital Management LP purchased a new stake in shares of scPharmaceuticals during the second quarter valued at $8,269,000. Finally, Thrivent Financial for Lutherans purchased a new stake in shares of scPharmaceuticals during the second quarter valued at $6,674,000. Institutional investors own 79.60% of the company’s stock.

scPharmaceuticals Stock Up 6.5 %

NASDAQ:SCPH traded up $0.35 during mid-day trading on Monday, reaching $5.73. The company’s stock had a trading volume of 279,225 shares, compared to its average volume of 234,425. scPharmaceuticals Inc. has a 1 year low of $4.63 and a 1 year high of $12.75. The stock has a fifty day moving average of $5.77 and a 200-day moving average of $6.33. The firm has a market capitalization of $205.48 million, a PE ratio of -3.93 and a beta of 0.01. The company has a quick ratio of 8.88, a current ratio of 9.53 and a debt-to-equity ratio of 0.78.

About scPharmaceuticals

(Free Report)

scPharmaceuticals Inc, a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure.

Recommended Stories

Want to see what other hedge funds are holding SCPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for scPharmaceuticals Inc. (NASDAQ:SCPHFree Report).

Institutional Ownership by Quarter for scPharmaceuticals (NASDAQ:SCPH)

Receive News & Ratings for scPharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for scPharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.